BCL2 and cancer: Furthermore, it was identified that the degradation of IκBα could be inhibited by PL and then suppressed the NF-κB activation and its translocation to the nucleus for function, which caused the downregulation of the anti-apoptosis protein BCL2 expression on various cancer cells [32,36,37].